Early cryoprecipitate for major haemorrhage in trauma: A randomised controlled feasibility trial

British Journal of Anaesthesia

Volumn 115, Issue 1, 2015, Pages 76-83

  Curry, N ^a   Rourke, C ^b   Davenport, R ^b   Beer, S ^a   Pankhurst, L ^c   Deary, A ^c   Thomas, H ^c   Llewelyn, C ^c   Green, L ^d   Doughty, H ^c   Nordmann, G ^e,f   Brohi, K ^b   Stanworth, S ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d BARTS HEALTH NHS TRUST   (United Kingdom)

^e PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

cryoprecipitate; fibrinogen; haemorrhagic shock; multiple trauma

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLEEDING; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; EMERGENCY HEALTH SERVICE; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INJURY; INJURY SEVERITY; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; LUNG EMBOLISM; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTE TRANSFUSION; THROMBOSIS; VEIN THROMBOSIS; BLOOD TRANSFUSION; COMPLICATION; HEMORRHAGE; MIDDLE AGED; PROCEDURES; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEASIBILITY STUDIES; FEMALE; FIBRINOGEN; GREAT BRITAIN; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; TRAUMA CENTERS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84936802105     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev134     Document Type: Article

References (25)

1. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schöchl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/? fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21: 74
2. Nienaber U, Innerhofer P, Westermann I, et al. The impact of fresh frozen plasma vs. coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42: 697-701
3. Schöchl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55
4. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51
5. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79-85
6. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level 1 trauma centre. J Trauma 2009; 66: 1616-24
7. Davenport R, Manson J, De'ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 1-7
8. Hiippala S, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
9. Yang L, Stanworth S, Baglin T. Cryoprecipitate: an outmoded treatment? Transfus Med 2012; 22: 315-20
10. Wikkelso A, Lunde J, Johansen M, et al. Fibrinogen in bleeding patients. Cochrane Database Syst Rev 2013; Issue. Art. No. CD008864
11. NHS Blood and Transplant. http://www. transfusionguide lines. org. uk/red-book (accessed 29 September 2014)
12. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376: 23-32
13. TARN Ps12: Trauma and Audit and Research Network Prediction Outcome Model. https://www. tarn. ac. uk/Content. aspx? ca=4&c=3065 (accessed 24 March 2014)
14. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-75
15. Altman DG, Schulz KF, Moher D, CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-94
16. Holcomb JB, Fox EE, Zhang X, et al. , PROMMTT Study Group. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg 2013; 75: S31-9
17. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility study. CMAJ 2013; 185: E583-9
18. CRASH-2 trial collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101
19. Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency in active or high-risk severe bleeding. Vox Sang 2008; 94: 221-6
20. Lee SH, Lee SM, Kim CS, et al. Fibrinogen recovery and changes in fibrin-based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest. Transfusion 2014; 54: 1379-87
21. Rahe-MeyerN, Solomon C, Hanke A, et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo controlled trial. Anesthesiology 2013; 118: 40-50
22. Curry N, Hopewell S, Dorée C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized control trials. Crit Care 2011; 15: R92
23. Klovaite J, Nordestgaard BG, Tybjaerg-Hansen A, Benn M. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Am J Respir Crit Care Med 2013; 187: 286-93
24. Van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are associated with the risk of deep venous thrombosis. J Thromb Haemost 2003; 1: 2677-8
25. Stec JJ, Silbershatz H, Tofler GH, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation 2000; 102: 1634-8